Rehard Robert 4
4 · REGAL REXNORD CORP · Filed Feb 11, 2026
Research Summary
AI-generated summary of this filing
Regal Rexnord (RRX) CFO Robert Rehard Sells 7,704 Shares
What Happened
Robert Rehard, Executive Vice President and Chief Financial Officer of Regal Rexnord Corp (RRX), sold 7,704 shares in an open-market sale on February 9, 2026. The reported weighted-average price was $216.72 per share, for total proceeds of approximately $1,669,611. This was a sale (code S), which is typically routine insider selling and not itself proof of company outlook.
Key Details
- Transaction date: February 9, 2026 (reported on Form 4 filed February 11, 2026). Filing appears to be within the standard two-business-day window.
- Price: Weighted average $216.72; actual prices ranged from $216.28 to $216.83 (see footnote F1 for breakdown availability).
- Shares sold: 7,704; proceeds ≈ $1,669,611.
- Shares owned after transaction: Not specified in the provided filing.
- Notable footnotes:
- F1: Weighted-average price; reporting person can provide per-price share counts on request.
- F2 & F3: Describe vesting schedules for stock appreciation rights (SARs) granted to the reporting person (40–100% over 2–5 years and 34–100% over 1–3 years, respectively). These relate to awards/vesting but not to this open-market sale.
Context
This was an outright sale of shares (S), not an option exercise or an award grant. Sales by corporate executives are common for reasons like diversification, taxes, or liquidity needs and do not necessarily indicate a change in company fundamentals. The filing includes additional footnotes about SAR vesting schedules; those are informational about other compensation arrangements and not evidence that SARs were exercised in this transaction.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-02-09$216.72/sh−7,704$1,669,611→ 34,153.954 total
- 2,164
Stock Appreciation Rights
[F2]Exercise: $76.99From: 2019-05-10Exp: 2027-05-10→ Common Stock (2,164 underlying) - 7,730
Stock Appreciation Rights
[F2]Exercise: $74.04From: 2020-05-09Exp: 2028-05-09→ Common Stock (7,730 underlying) - 15,382
Stock Appreciation Rights
[F2]Exercise: $78.05From: 2021-05-08Exp: 2029-05-08→ Common Stock (15,382 underlying) - 12,340
Stock Appreciation Rights
[F3]Exercise: $84.39From: 2021-02-18Exp: 2030-02-18→ Common Stock (12,340 underlying) - 9,276
Stock Appreciation Rights
[F3]Exercise: $133.77From: 2022-02-23Exp: 2031-02-23→ Common Stock (9,276 underlying) - 8,292
Stock Appreciation Rights
[F3]Exercise: $151.27From: 2023-02-23Exp: 2032-02-23→ Common Stock (8,292 underlying) - 9,456
Stock Appreciation Rights
[F3]Exercise: $154.20From: 2024-02-23Exp: 2033-02-23→ Common Stock (9,456 underlying) - 7,657
Stock Appreciation Rights
[F3]Exercise: $168.47From: 2025-02-23Exp: 2034-02-23→ Common Stock (7,657 underlying)
Footnotes (3)
- [F1]The price in Column 4 is a weighted average price. The prices actually received ranged from $216.28 to $216.83. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
- [F2]The Stock Appreciation Rights vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
- [F3]The Stock Appreciation Rights vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.